Mycotoxin Testing Market Size and Share
Mycotoxin Testing Market Analysis by Mordor Intelligence
The global mycotoxin testing market is expected to reach a size of USD 2.13 billion in 2025 and is projected to expand to USD 3.08 billion by 2030, at a CAGR of 7.67% during the forecast period. This growth trajectory reflects the escalating regulatory pressure following high-profile contamination incidents, including France's rejection of Turkish dried figs due to aflatoxin levels exceeding legal limits by 20 times in December 2024 and the tragic death of 450 dogs in Malawi from aflatoxin-contaminated maize. Chromatography-based platforms remain the benchmark for confirmatory analysis, yet rapid test kits are gaining ground as processors seek point-of-use screening. Climate-linked shifts in fungal prevalence, such as the surge in Fusarium toxins, further underpin routine testing demand. Global laboratories scale capacity in response to the European Union’s Regulation 2023/915 and the United States’ LAAF mandates, while Asia-Pacific laboratories add accredited instrumentation to serve rising export volumes according to FDA (Food and Drug Administration [1]Source: European Union,"Commission Regulation (EU)", eur-lex.europa.eu.
Key Report Takeaways
By technology type, the chromatography-based segment led with 37.34% revenue share in 2024; rapid test kits are forecast to expand at a 9.12% CAGR through 2030.
By mycotoxin type, aflatoxins accounted for 30.13% of the mycotoxin testing market share in 2024, while Fusarium toxins are projected to grow at 9.56% CAGR through 2030.
By tested commodity, the food segment held 82.47% share of the mycotoxin testing market size in 2024, whereas pet food and animal feed testing are set to rise at an 8.89% CAGR between 2025-2030.
By geography, North America contributed 34.89% revenue share in 2024 and Asia-Pacific is forecast to advance at a 9.45% CAGR through 2030.
Global Mycotoxin Testing Market Trends and Insights
Drivers Impact Analysis
Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Consumer awareness of food safety | +1.2% | North America, European Union | Medium term (2-4 years) |
Stringent food safety regulations | +2.1% | European Union, North America | Long term (≥ 4 years) |
Increased contamination incidents | +1.8% | Climate-vulnerable regions worldwide | Short term (≤ 2 years) |
Advancements in testing technologies | +1.5% | Developed markets | Medium term (2-4 years) |
Source: Mordor Intelligence
Stringent Food Safety Regulations
Regulatory tightening has fundamentally reshaped testing requirements, with the EU's Regulation 2023/915 consolidating maximum contaminant levels and introducing binding limits for T-2 and HT-2 toxins effective July 2024. The FDA's [2]Source: Food and Drug Administration, "Mycotoxins in Domestic and Imported Human Foods Compliance Program", www.fda.gov expansion of its Mycotoxins in Domestic and Imported Human Foods Compliance Program to include T-2/HT-2 toxins and zearalenone monitoring represents a parallel enforcement escalation. These regulatory shifts create cascading compliance costs that favor larger testing laboratories with advanced analytical capabilities. The implementation of limit of quantification requirements differentiating screening from confirmatory methods has particularly advantaged chromatography-based testing over traditional approaches. Australia's integration of food safety requirements into the Biosecurity Import Conditions system effective June 2025 exemplifies the global trend toward streamlined yet more rigorous import controls [3]Source: Australian Department of Agriculture, " Improving access to imported food safety requirements", www.agriculture.gov.auaccording to the Australian Department of Agriculture.
Increased Contamination Incidents in Grains, Nuts, and Processed Foods
Driven by climate-induced contamination patterns, testing demand has surged. In 2022, Serbia reported that 73.2% of its maize samples surpassed EU aflatoxin B1 limits, with peak levels hitting 527 µg/kg, as noted by MDPI (Multidisciplinary Digital Publishing Institute). The European Food Safety Authority has broadened testing protocols, identifying emerging risks like engineered nanomaterials and rare earth elements infiltrating food chains. Highlighting the ongoing fungal threats, Japan's Ministry of Health, Labour and Welfare flagged multiple mold detection incidents in 2024-2025, including in sweet potato products and rice cakes. There's a growing recognition of the link between temperature and humidity fluctuations and mycotoxin levels, with elevated warmth and moisture leading to heightened contamination. This heightened climate sensitivity has shifted the focus towards proactive testing strategies, moving away from mere reactive contamination management.
Advancements in Testing Technologies
VICAM's Vertu TOUCH strip test reader, a testament to the rapid evolution in technology, delivers quantitative results for six primary mycotoxins in just 10 minutes, all without the necessity for specialized training.Hyperspectral imaging integrated with machine learning algorithms has emerged as a non-destructive detection method, offering real-time monitoring capabilities for industrial applications. The development of silicon-core quantum dot fluorescent probes has achieved detection limits as low as 0.25 ng/mL for vomitoxin in cereals, with average recovery rates exceeding 92%. By integrating with nanomaterials, surface-enhanced Raman spectroscopy platforms have boosted their sensitivity, overcoming past challenges like signal stability and interference from intricate food matrices. Thanks to these technological leaps, results that once took hours can now be achieved in mere minutes, all while upholding the analytical precision of conventional chromatographic methods.
Expansion of Certified Testing Laboratories in Emerging Markets
Laboratory infrastructure development in Asia-Pacific has accelerated, with Japan Food Research Laboratories expanding mycotoxin testing capabilities using LC-MS/MS and PCR technologies. India's FSSAI extended the implementation date for mandatory registration of foreign food manufacturing facilities to September 2024, creating demand for accredited testing services according to USDA [4]Source: U.S Department of Agriculture, "India's FSSAI Extends Effective Implementation Date for Mandatory Registration of Foreign Food Manufacturing Facilities", www.fas.usda.gov. The CDC's [5]Source: Centers for Disease Control and Prevention (CDC),"NOFO CD-25-0019", www.cdc.govfunding opportunity NOFO CD-25-0019 allocated resources to enhance public health laboratory capabilities, with a 5-year funding period starting July 2025. Michigan's groundbreaking of a 300,000-square-foot public health and environmental science laboratory, scheduled for completion in late 2026 with a USD 326 million budget, exemplifies the infrastructure investments driving capacity expansion. These developments reflect the strategic shift toward distributed testing networks that reduce dependency on centralized facilities.
Restraints Impact Analysis
Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
High cost of advanced equipment and reagents | -1.4% | Developing regions | Medium term (2-4 years) |
Shortage of skilled technicians | -0.9% | Emerging markets | Medium term (2-4 years) |
Source: Mordor Intelligence
High Cost of Advanced Testing Equipment and Reagents
Advanced LC-MS/MS systems, pivotal for mycotoxin testing, demand hefty investments surpassing USD 500,000. This figure doesn't account for the annual reagent expenses, which can soar to USD 100,000, especially in high-throughput labs. Adding to the industry's woes, the FDA is reportedly eyeing a 17% budget cut for FY 2026. Such a move could halt the Proficiency Testing Program for food labs, jeopardizing quality control and inflating compliance costs for private entities. Furthermore, crafting certified reference materials for intricate matrices—like corn/peanut blended vegetable oil—demands significant outlays in method validation and inter-laboratory studies. These financial and operational challenges are further compounded by the need for continuous training of laboratory personnel to handle advanced systems effectively. Additionally, the lack of uniform global regulations for mycotoxin testing creates inconsistencies in testing standards, complicating international trade. As cost pressures mount, many are turning to rapid testing alternatives, albeit often at the expense of analytical precision in favor of quicker results.
Shortage of Skilled Technicians for Handling Complex Instruments
Laboratories, especially those delving into advanced analytical techniques like chromatography and mass spectrometry, grapple with workforce limitations that hinder their capacity expansion. For instance, analyzing multiple mycotoxins with integrated systems, such as the ASAG563 for trichothecenes, necessitates a high level of expertise in method optimization and troubleshooting. Moreover, as laboratories adopt emerging technologies like gas chromatography-ion mobility spectrometry for early detection of Aspergillus contamination, they face heightened training demands. The shift from conventional methods to AI-driven detection systems underscores the need for a blend of skills, merging analytical chemistry with data science. However, workforce development initiatives have lagged behind these technological strides, leading to productivity bottlenecks and curtailing the adoption of cutting-edge testing protocols.
Segment Analysis
By Technology Type: Rapid Innovation Drives Market Evolution
In 2024, chromatography-based technologies held a commanding 37.34% market share, bolstered by regulatory mandates for confirmatory analyses and the heightened precision required for trace-level detections. Meanwhile, rapid test kits emerged as the industry's fastest-growing segment, boasting a 9.12% CAGR projected through 2030, underscoring a pronounced shift towards point-of-use testing. Waters Corporation's launch of the waters_connect Data Intelligence software in November 2024 highlights the industry's pivot, steering chromatographic platforms towards cloud-centric business intelligence and heightened audit readiness. While immunoassay methods remain the go-to for primary screenings, there's a noticeable uptick in the adoption of spectroscopy and biosensor methods for real-time monitoring.
Artificial intelligence's integration with conventional analytical techniques is carving out a competitive edge. Notably, machine learning algorithms are refining hyperspectral imaging's accuracy for mycotoxin detection in cereal grains, as highlighted by MDPI (Multidisciplinary Digital Publishing Institute). Innovations in nanotechnology and microfluidics are propelling the momentum of other technologies, such as novel biosensor platforms and portable detection devices. Furthermore, advancements like time-resolved fluorescence immunoassays, which now detect aflatoxin B1 at an impressive 0.3 µg/kg limit, underscore the industry's relentless pursuit of heightened sensitivity across all platforms.
Note: Segment shares of all individual segments available upon report purchase
By Mycotoxin Type: Fusarium Toxins Emerge as Growth Driver
In 2024, aflatoxins held a dominant 30.13% share of the market, underscoring their position as the world's most stringently regulated mycotoxin class. Meanwhile, Fusarium toxins emerged as the fastest-growing category, boasting a 9.56% CAGR projected through 2030. The European Union's introduction of binding limits for T-2 and HT-2 toxins, set to take effect in July 2024, has spurred a surge in testing demand for these compounds, which were previously not as closely monitored. Testing for Ochratoxin A remains consistently in demand, largely due to the needs of the wine and coffee sectors, whereas patulin testing is predominantly centered on fruit products.
Advancements in multi-mycotoxin detection platforms have revolutionized the economics of testing. For instance, lateral flow immunoassays can now simultaneously detect aflatoxin B1, zearalenone, and T-2 toxin in just 20 minutes, as reported by MDPI (Multidisciplinary Digital Publishing Institute). A tragic reminder of the dangers posed by aflatoxins is the incident in Malawi, where 450 dogs lost their lives due to aflatoxin-contaminated maize. On a proactive note, Spectral Blue has pioneered a Multi-Wavelength, High-Intensity blue light technology, aiming to diminish deoxynivalenol levels in tainted grains, marking a significant stride in post-harvest mycotoxin management.
By Tested Commodity: Pet Food Segment Accelerates
In 2024, the food segment dominated the market with an 82.47% share, covering categories like meat, poultry, dairy, fruits, vegetables, and processed foods. However, the pet food and animal feed testing segment is emerging as the fastest-growing, boasting an 8.89% CAGR projected through 2030. A notable driver of this growth is Taiwan's July 2024 move to set safety tolerance levels for five additional mycotoxins in pet food. This includes specific limits for vomitoxin and fumonisin. Within the broader food category, testing has intensified: processed food scrutiny heightened after contamination incidents, dairy testing zeroes in on aflatoxin M1, and fruits and vegetables testing targets patulin and other mycotoxins.
Advanced optical sorting technologies are reshaping pet food safety. Bühler's SORTEX LumoVision, for instance, can slash aflatoxin levels by up to 90% using fluorescence to detect contaminated kernels. As regulatory frameworks broaden, there's a surge in testing demands for other food categories, notably specialty products and nutraceuticals. The FDA's post-October 2024 enforcement policy for AAFCO-defined animal feed ingredients has set clear regulatory expectations for novel feed components, all while upholding stringent safety standards.

Note: Segment shares of all individual segments available upon report purchase
Geography Analysis
In 2024, North America secured a commanding lead with a 34.89% market share, thanks to stringent FDA enforcement and a robust testing infrastructure. The Asia-Pacific region, however, is making waves, projecting a notable 9.45% CAGR through 2030. Demonstrating its dedication, the FDA has set aside USD 15 million in its FY 2025 budget, zeroing in on microbiological and chemical safety. Europe benefits from harmonized regulations under EU Regulation 2023/915, yet Brexit has complicated trade dynamics between the UK and the EU.
In South America, key grain-producing regions are battling climate-induced contamination issues. Concurrently, the Middle East and Africa are bolstering their testing infrastructures to meet export standards. Japan's swift action on mold detection, following several contamination incidents in 2024-2025, underscores the region's dedication to food safety. India's FSSAI has extended foreign facility registration requirements to September 2024, signaling the shifting regulatory landscape in emerging markets.
Canada's 2024-2025 departmental plan prioritizes regulatory modernization and boosts laboratory capacity for disease detection, reinforcing the region's testing infrastructure. Meanwhile, the European Environment Agency warns of mycotoxin exposure due to shifting climate conditions, stressing the urgency for adaptive testing strategies.

Note: Segment shares of all Individual segments will be available upon report purchase
Competitive Landscape
The mycotoxin testing market is moderately fragmented, marked by fierce competition among established laboratory service providers and manufacturers of analytical instruments. Some of the major players include DSM-Firmenich, Eurofins Scientific, and SGS Société Générale de Surveillance SA, among others. A notable instance of strategic consolidation is Mérieux NutriSciences' acquisition of Bureau Veritas' food testing business for EUR 360 million in October 2024. This move has birthed a unified entity boasting 34 laboratories worldwide and a workforce exceeding 1,900.
Companies are heavily investing in AI-driven analytical solutions and cloud-based data management systems, focusing on technology differentiation through automation capabilities, multi-analyte detection platforms, and seamless integration with digital infrastructure. Eurofins Scientific's revenue surged by 6.7% in the first three quarters of 2024, hitting EUR 5,142 million, underscoring the market's significant growth potential. Patent filings are predominantly centered on enhancing analytical methods and innovating detection technologies, with a notable emphasis on novel biosensor designs and advanced sample preparation techniques.
New entrants, particularly specialized biosensor developers and manufacturers of rapid testing kits, are redefining the landscape, offering point-of-use solutions that rival traditional laboratory models. While technology frontrunners harness proprietary analytical methods and navigate regulatory landscapes for a competitive edge, smaller entities carve out niches in specific applications or regional markets. The FDA's Laboratory Flexible Funding Model Cooperative Agreement Program, with its allocation of USD 23.2 million aimed at bolstering state laboratory capabilities, paves the way for collaborative ventures between public entities and private firms in advancing testing infrastructure.
Mycotoxin Testing Industry Leaders
-
DSM-Firmenich
-
Eurofins Scientific
-
SGS Société Générale de Surveillance SA.
-
Institut Mérieux
-
Thermo Fisher Scientific Inc.
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- June 2025: Thermo Fisher Scientific unveiled next-generation Orbitrap Astral Zoom and Orbitrap Excedion Pro mass spectrometers at ASMS 2025, offering 35% faster scan speeds and 40% higher throughput for enhanced proteomics and biopharmaceutical applications.
- February 2025: Mérieux NutriSciences completed acquisition of Bureau Veritas' worldwide food testing business for EUR 360 million, expanding operations to 32 countries and doubling presence in Canada and Asia-Pacific.
- July 2024: Taiwan introduced safety tolerance levels for 5 additional mycotoxins in pet food, including vomitoxin, fumonisin, zearalenone, ochratoxin, and T-2 mycotoxin, enhancing pet food safety standards.
- July 2024: SGS North America announced expansion of biologics testing capabilities at Lincolnshire Center of Excellence, adding new instrumentation and scientific expertise for biopharmaceutical market.
Global Mycotoxin Testing Market Report Scope
The global mycotoxin testing market is segmented by technology into HPLC-based, LC-MS/MS-based, Immunoassay-based, and Other Technologies. By pathogen type into Aflatoxins, Ochratoxin A, Patulin, Fusarium Toxins, Other Mycotoxins. By application into beverages and foods. By geography, the scope includes North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
By Technology Type | Chromatography-based | ||
Immunoassay-based | |||
Rapid Test Kits | |||
Spectroscopy and Biosensor-based | |||
Other Technologies | |||
By Mycotoxin Type | Aflatoxins | ||
Ochratoxin A | |||
Patulin | |||
Fusarium Toxins | |||
Other Mycotoxins | |||
By Tested Commodity | Food | Meat and Poultry | |
Dairy | |||
Fruits and Vegetables | |||
Processed Food | |||
Other Food | |||
Pet Food and Animal Feed | |||
By Geography | North America | United States | |
Canada | |||
Mexico | |||
Rest of North America | |||
Europe | United Kingdom | ||
Germany | |||
Spain | |||
France | |||
Italy | |||
Russia | |||
Rest of Europe | |||
Asia-Pacific | China | ||
India | |||
Japan | |||
Australia | |||
Rest of Asia Pacific | |||
South America | Brazil | ||
Argentina | |||
Rest of South America | |||
Middle East and Africa | Saudi Arabia | ||
South Africa | |||
Rest of Middle East and Africa |
Chromatography-based |
Immunoassay-based |
Rapid Test Kits |
Spectroscopy and Biosensor-based |
Other Technologies |
Aflatoxins |
Ochratoxin A |
Patulin |
Fusarium Toxins |
Other Mycotoxins |
Food | Meat and Poultry |
Dairy | |
Fruits and Vegetables | |
Processed Food | |
Other Food | |
Pet Food and Animal Feed |
North America | United States |
Canada | |
Mexico | |
Rest of North America | |
Europe | United Kingdom |
Germany | |
Spain | |
France | |
Italy | |
Russia | |
Rest of Europe | |
Asia-Pacific | China |
India | |
Japan | |
Australia | |
Rest of Asia Pacific | |
South America | Brazil |
Argentina | |
Rest of South America | |
Middle East and Africa | Saudi Arabia |
South Africa | |
Rest of Middle East and Africa |
Key Questions Answered in the Report
What is the current size of the mycotoxin testing market?
The market is valued at USD 2,132 million in 2025 and is forecast to reach USD 3,085.52 million by 2030.
Which testing technology holds the largest share?
Chromatography platforms lead with 37.34% revenue share in 2024, reflecting their role in confirmatory analysis.
Why are Fusarium toxins attracting more attention?
Climate shifts have raised Fusarium contamination levels, and new EU limits introduced in 2024 mandate greater surveillance.
Which region is growing the fastest?
Asia-Pacific is projected to register a 9.45% CAGR through 2030, driven by expanding export-oriented testing capacity.
How will rapid test kits impact the future landscape?
Rapid kits are set to grow at 9.12% CAGR, enabling on-site screening and faster release of shipments without sacrificing accuracy.